| 摘要 |
Anthelmintically active compounds of formula I are described <IMAGE> in which R1 is hydrogen, halogen, C1-C2alkyl, C1-C2thioalkyl, C1-C2 haloalkyl, nitro, C1-C2alkoxy, or the group SOnR in which R is C1-C2alkyl or phenyl and n is 0, 1 or 2; R2 is hydrogen, halogen, C1-C2alkyl, C1-C2haloalkyl, C1-C2haloalkoxy or C1-C2alkoxy; R3 is hydrogen or C1-C2alkyl; R4 is hydrogen or C1-C2alkyl; R5 is hydrogen, halogen or C1-C5alkyl; R6 is hydrogen, halogen or C1-C5alkyl; R7 is hydrogen, halogen, C1-C2alkyl, nitro, C1-C2haloalkyl, C1-C2haloalkoxy or C1-C2alkoxy; R8 is hydrogen, halogen, C1-C2alkyl, C1-C2haloalkyl, C1-C2haloalkoxy or C1-C2alkoxy; R9 is hydrogen, halogen, C1-C2alkyl, C1-C2haloalkyl, C1-C2haloalkoxy or C1-C2alkoxy; R10 is hydrogen, halogen, C1-C6alkyl, C1-C2haloalkyl, C1-C2alkylthio, C3-C6cycloalkyl or cyano; R11 is hydrogen, halogen, C1-C6alkyl, C1-C2haloalkyl, C1-C2alkylthio or C3-C6cycloalkyl; R12 is hydrogen or halogen; and Y is =CH- or =N-; including the physiologically tolerable acid additon salts thereof, and also the preparatin and use thereof and novel intermediates.
|
